
Key facts: JP Morgan cuts Vera Therapeutics price target to $52; company announces inducement grants
JP Morgan has reduced its price target for Vera Therapeutics from $53.00 to $52.00 per share.1Vera Therapeutics announced inducement grants in accordance with Nasdaq Listing Rule 5635(C)(4).2
- JP Morgan has reduced its price target for Vera Therapeutics from $53.00 to $52.00 per share.1
- Vera Therapeutics announced inducement grants in accordance with Nasdaq Listing Rule 5635(C)(4).2

